Funding Alert Vol. 31 No. 10 Alert # 3 - October 20, 2020

Texas Department of State Health Services Funding Information Center Toll free: 1-888-963-7111 ext. 7684 Austin phone: (512) 776-7684 Fax: (512) 776-7683


The Texas Department of State Health Services Funding Information Center Funding Alert is published weekly. To subscribe to the Funding Alert and other services, please complete the online subscription form at dshs.texas.gov/fic/subscribe.aspx. Information in the Funding Alert is not copyrighted and may be reproduced. TX DSHS FIC would appreciate credit for the material used and a copy of the reprint.


Disclaimer: External links to other sites are intended to be informational and do not have the endorsement of the Department of State Health Services. These sites may also not be accessible to persons with disabilities. External e-mail links are provided to you as a courtesy. Please be advised that you are not e-mailing the Texas Department of State Health Services (DSHS) and DSHS policies do not apply should you choose to correspond.

TX DSHS Funding Information Center services are limited to Texas residents only.


Funding News and Grant Tips

America’s HIV Epidemic Analysis Dashboard (AHEAD) 
The U.S. Department of Health and Human Services (HHS), through its Office of Infectious Disease and HIV/AIDS Policy (OIDP), has developed a unique data visualization tool. America’s HIV Epidemic Analysis Dashboard (AHEAD) graphically visualizes data on the six indicators used to track progress towards ending the HIV epidemic (EHE) in America. By tracking progress, jurisdictions, communities and stakeholders will be able to monitor movement towards reducing new HIV transmissions by at least 90 percent by 2030. This tool is envisioned to be an asset that will provide the most up to date information available about EHE progress to help inform national and jurisdictional decision making. To access the tool, go to https://ahead.hiv.gov/?s_cid=em_nchhstpcon202009160005.
From CDC National Prevention Information Network's (NPIN) HIV/Hepatitis/STD/TB Funding Information email, Sept. 23, 2020.

One in Four Rural Families Could Not Get Health Care During Pandemic
Nearly a quarter (24 percent) of rural households have experienced difficulty in receiving medical care for a serious health issue since the COVID-19 pandemic began, a report from the Robert Wood Johnson Foundation, Harvard T.H. Chan School of Public Health and National Public Radio finds. The fourth in a series of reports based on a survey of nearly thirty-five hundred adults conducted between July 1 and August 3, The Impact of Coronavirus on Households in Rural America  (56 pages, PDF) found that of those respondents who said a family member could not get medical care — either because they could not get an appointment during the hours that worked for their schedule (46 percent), could not find a doctor who would see them (40 percent) or could not afford that care (39 percent) — 56 percent reported negative health consequences as a result. Nearly half (46 percent) of rural respondents said someone in their household had used a telehealth platform. The report can be found at https://cdn1.sph.harvard.edu/wp-content/uploads/sites/94/2020/10/Rural-Report_100520-FINAL.pdf.
From Philanthropy News Digest website, accessed Oct. 13, 2020.

Public Funding Opportunities

Centers to Advance Research in Endometriosis (CARE) (P01 Clinical Trial Not Allowed): RFA-HD-21-002
SOURCE: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Cancer Institute (NCI), National Institute of Environmental Health Sciences (NIEHS)
APPLICATION DEADLINE: Letter of Intent: Oct. 30, 2020. Due Date: Nov. 30, 2020.
$ AVAILABLE: The NICHD and partner components intend to commit $3.8 million in total costs in Fiscal Year (FY) 2021 to fund two to three awards.
ELIGIBILITY: 
• Public/state/private controlled institutions of higher education.
• Hispanic-serving institutions.
• Historically Black Colleges and Universities (HBCUs).
• Tribally Controlled Colleges and Universities (TCCUs).
• Alaska native and native Hawaiian serving institutions.
• Asian American Native American Pacific Islander Serving Institutions (AANAPISIs).
• Nonprofits with or without 501(c)(3) IRS status (other than institutions of higher education).
• Small businesses.
• For-profit organizations (other than small businesses).
• State governments.
• County governments.
• City or township governments.
• Special district governments.
• Indian/Native American tribal governments (federally recognized and other than federally recognized).
• Eligible agencies of the federal government.
• U.S. territories or possessions.
• Independent school districts.
• Public housing authorities/Indian housing authorities.
• Native American tribal organizations (other than federally recognized tribal governments).
• Faith-based or community-based organizations.
• Regional organizations.
PURPOSE: The purpose of this Funding Opportunity Announcement (FOA) is to support the novel development of Centers to Advance Research in Endometriosis (CARE).  These multidisciplinary programs will incorporate basic, translational or clinical studies (excluding clinical trials) in a collaborative entity to accelerate research advances through sharing of knowledge and resources. The goal of the program is to improve female reproductive health through successful prevention and treatment of endometriosis.  
CFDA: 93.865, 93.393, 93.113, 93.313 
CONTACT: Application Submission Contacts: 
• eRA Service Desk (Questions regarding ASSIST, eRA Commons, application errors and warnings, documenting system problems that threaten submission by the due date and post-submission issues).
Finding Help Online: grants.nih.gov/support/ (preferred method of contact). Phone: 301-402-7469 or 866-504-9552 (Toll Free).
• General Grants Information (Questions regarding application instructions, application processes and NIH grant resources): Email: GrantsInfo@nih.gov (preferred method of contact). Phone: 301-945-7573.
• Grants.gov Customer Support (Questions regarding Grants.gov registration and Workspace): Contact Center Phone: 800-518-4726. Email: support@grants.gov. For more information, go to https://grants.nih.gov/grants/guide/rfa-files/RFA-HD-21-002.html.
From Grants.gov website, accessed Oct. 13, 2020. 
Subject(s): women’s health.

Emerging Infections Network - Research for Preventing, Detecting and Managing Travelers who Acquire Infectious Diseases Abroad: RFA-CK-21-002
SOURCE: Centers for Disease Control and Prevention (CDC)
APPLICATION DEADLINE: Letter of Intent: Nov. 16, 2020. Due Date: Dec. 18, 2020.
$ AVAILABLE: One award of $7.5 million over five years.
ELIGIBILITY: 
• Public/state/private controlled institutions of higher education.
• Hispanic-serving institutions.
• Historically Black Colleges and Universities (HBCUs).
• Tribally Controlled Colleges and Universities (TCCUs).
• Alaska native and native Hawaiian serving institutions.
• Asian American Native American Pacific Islander Serving Institutions (AANAPISIs).
• Nonprofits with or without 501(c)(3) IRS status (other than institutions of higher education).
• Small businesses.
• For-profit organizations (other than small businesses).
• State governments.
• County governments.
• City or township governments.
• Special district governments.
• Indian/Native American tribal governments (federally recognized and other than federally recognized).
• Eligible agencies of the federal government.
• U.S. territories or possessions.
• Independent school districts.
• Public housing authorities/Indian housing authorities.
• Native American tribal organizations (other than federally recognized tribal governments).
• Faith-based or community-based organizations.
• Regional organizations.
PURPOSE: The purpose of this notice of funding opportunity (NOFO) is to support research activities that will assist with the prevention, detection and management of international travelers who become ill during or after travel. The project must have a focus on travel and tropical medicine providers with the capability to participate in research to determine the disease prevention strategies, burden, severity, optimal diagnostics, treatment interventions and outcomes of infectious diseases acquired while travelling abroad. This research will bridge the gap between clinical medicine and public health by assisting with improving patient care, better understanding the natural history of disease, and implementing optimal diagnostic and treatment strategies, with the ultimate outcome being an advancement in the global health security of the United States.
CFDA: 93.084, 93.860 
CONTACT: Application Submission Contacts: 
• eRA Service Desk (Questions regarding ASSIST, eRA Commons, application errors and warnings, documenting system problems that threaten submission by the due date and post-submission issues).
Finding Help Online: grants.nih.gov/support/ (preferred method of contact). Phone: 301-402-7469 or 866-504-9552 (Toll Free).
• General Grants Information (Questions regarding application instructions, application processes and NIH grant resources): Email: GrantsInfo@nih.gov (preferred method of contact). Phone: 301-945-7573.
• Grants.gov Customer Support (Questions regarding Grants.gov registration and Workspace): Contact Center Phone: 800-518-4726. Email: support@grants.gov. For more information, go to https://www.grants.gov/web/grants/search-grants.html?keywords=RFA-ck-21-002.
From CDC National Prevention Information Network's (NPIN) HIV/Hepatitis/STD/TB Funding Information email, Oct. 8, 2020. 
Subject(s): medical research, travel, infectious diseases.

Investigation of the Transmission of Kaposi Sarcoma-Associated Herpesvirus (KSHV) (R01 Clinical Trial Optional): RFA-CA-20-046
SOURCE: National Cancer Institute (NCI)
APPLICATION DEADLINE: Letter of Intent: Nov. 15, 2020, Nov. 14, 2021. Due Date: Dec. 15, 2020, Dec. 14, 2021.
$ AVAILABLE: NCI intends to commit $3 million in each of two fiscal years 2021 and 2022 to fund an estimate of four to six awards each year. Future year amounts will depend on annual appropriations.
ELIGIBILITY: 
• Public/state/private controlled institutions of higher education.
• Hispanic-serving institutions.
• Historically Black Colleges and Universities (HBCUs).
• Tribally Controlled Colleges and Universities (TCCUs).
• Alaska native and native Hawaiian serving institutions.
• Asian American Native American Pacific Islander Serving Institutions (AANAPISIs).
• Nonprofits with or without 501(c)(3) IRS status (other than institutions of higher education).
• Small businesses.
• For-profit organizations (other than small businesses).
• State governments.
• County governments.
• City or township governments.
• Special district governments.
• Indian/Native American tribal governments (federally recognized and other than federally recognized).
• Eligible agencies of the federal government.
• U.S. territories or possessions.
• Independent school districts.
• Public housing authorities/Indian housing authorities.
• Native American tribal organizations (other than federally recognized tribal governments).
• Faith-based or community-based organizations.
• Regional organizations.
• Non-domestic (non-U.S.) entities (foreign institutions).
PURPOSE: Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) intends to advance our understanding of the modes of transmission of Kaposi sarcoma-associated herpesvirus (KSHV), also called human herpesvirus-8 (HHV-8), and the biology of the initial steps of infection and the risk factors for infection. Such studies should inform and advance efforts to reduce or eliminate KSHV transmission and thus prevent Kaposi sarcoma (KS), KSHV-associated multicentric Castleman disease (MCD), primary effusion lymphoma (PEL) and other KSHV-induced diseases in populations living with HIV or at high risk of HIV infection.
CFDA: 93.393, 93.394, 93.395, 93.396, 93.399
CONTACT: Application Submission Contacts: 
• eRA Service Desk (Questions regarding ASSIST, eRA Commons, application errors and warnings, documenting system problems that threaten submission by the due date and post-submission issues).
Finding Help Online: grants.nih.gov/support/ (preferred method of contact). Phone: 301-402-7469 or 866-504-9552 (Toll Free).
• General Grants Information (Questions regarding application instructions, application processes and NIH grant resources): Email: GrantsInfo@nih.gov (preferred method of contact). Phone: 301-945-7573.
Grants.gov Customer Support (Questions regarding Grants.gov registration and Workspace): Contact Center Phone: 800-518-4726. Email: support@grants.gov. For more information, go to http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-20-046.html.
From CDC National Prevention Information Network's (NPIN) HIV/Hepatitis/STD/TB Funding Information email Oct. 1, 2020. 
Subject(s): HIV/AIDS research, cancer research.

Late-Stage Translation of Biomedical and Behavioral Research Results in Arthritis and Musculoskeletal and Skin Diseases from Academic/Nonprofit Lab to Marketplace (SBIR [R43/R44] Clinical Trial Not Allowed): PAR-21-030
SOURCE: National Institutes of Health (NIH)
APPLICATION DEADLINE: Letter of Intent: Dec. 5, 2020. Due Date: Jan. 5, 2021.
$ AVAILABLE: The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.
ELIGIBILITY: Only United States small business concerns (SBCs) are eligible to submit applications for this opportunity.
PURPOSE: This Funding Opportunity Announcement (FOA) solicits Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that translate technology and therapeutic innovations from academic and other nonprofit research sectors to the marketplace to advance the development of diagnostic and prevention tools or treatments for musculoskeletal, rheumatic or skin diseases. It supports late-stage pre-clinical research and development, such as moving products towards regulatory approval for clinical testing or making the new lab technologies more practical to use in a clinical setting. It requires close collaboration between the original developers of these technologies and the SBCs.
CFDA: 93.846
CONTACT: Application Submission Contacts: 
• eRA Service Desk (Questions regarding ASSIST, eRA Commons, application errors and warnings, documenting system problems that threaten submission by the due date and post-submission issues).
Finding Help Online: grants.nih.gov/support/ (preferred method of contact). Phone: 301-402-7469 or 866-504-9552 (Toll Free).
• General Grants Information (Questions regarding application instructions, application processes and NIH grant resources): Email: GrantsInfo@nih.gov (preferred method of contact). Phone: 301-945-7573.
• Grants.gov Customer Support (Questions regarding Grants.gov registration and Workspace): Contact Center Phone: 800-518-4726. Email: support@grants.gov. For more information, go to https://grants.nih.gov/grants/guide/pa-files/PAR-21-030.html.
From Grants.gov website, accessed Oct. 13, 2020. 
Subject(s): medical research, technology, musculoskeletal diseases, skin and connective tissue diseases.

Multidisciplinary Approaches to HIV-Associated Comorbidities and Prioritizing Intervention Targets (R01 Clinical Trial Not Allowed): PAR-21-027
SOURCE: National Institutes of Health (NIH)
APPLICATION DEADLINE: Letter of Intent: Dec. 7, 2020, April 7, 2021, Dec 7. 2021, April 7, 2022, Dec. 7, 2022. Due Date: Jan. 7, 2021, May 7, 2021, Jan. 7, 2022, May 7, 2022, Jan. 7, 2023 by 5 p.m. local time of applicant organization.
$ AVAILABLE: The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.
ELIGIBILITY: 
• Public/state/private controlled institutions of higher education.
• Hispanic-serving institutions.
• Historically Black Colleges and Universities (HBCUs).
• Tribally Controlled Colleges and Universities (TCCUs).
• Alaska native and native Hawaiian serving institutions.
• Asian American Native American Pacific Islander Serving Institutions (AANAPISIs).
• Nonprofits with or without 501(c)(3) IRS status (other than institutions of higher education).
• Small businesses.
• For-profit organizations (other than small businesses).
• State governments.
• County governments.
• City or township governments.
• Special district governments.
• Indian/Native American tribal governments (federally recognized and other than federally recognized).
• Eligible agencies of the federal government.
• U.S. territories or possessions.
• Independent school districts.
• Public housing authorities/Indian housing authorities.
• Native American tribal organizations (other than federally recognized tribal governments).
• Faith-based or community-based organizations.
• Regional organizations.
PURPOSE: This Funding Opportunity Announcement (FOA) seeks applications for comprehensive systems biology studies using multidisciplinary team science to identify common, overlapping etiologies of HIV-associated comorbidities. Ultimately, the goal is to identify targets for intervention to mitigate multiple comorbidities associated with HIV infection.
CFDA: 93.837, 93.838, 93.839, 93.840, 93.233
CONTACT: Application Submission Contacts: 
• eRA Service Desk (Questions regarding ASSIST, eRA Commons, application errors and warnings, documenting system problems that threaten submission by the due date and post-submission issues).
Finding Help Online: grants.nih.gov/support/ (preferred method of contact). Phone: 301-402-7469 or 866-504-9552 (Toll Free).
• General Grants Information (Questions regarding application instructions, application processes and NIH grant resources): Email: GrantsInfo@nih.gov (preferred method of contact). Phone: 301-945-7573.
• Grants.gov Customer Support (Questions regarding Grants.gov registration and Workspace): Contact Center Phone: 800-518-4726. Email: support@grants.gov. For more information, go to https://grants.nih.gov/grants/guide/pa-files/PAR-21-027.html.
From Grants.gov website, accessed Oct. 13, 2020. 
Subject(s): HIV/AIDS research.

NIAID Research Education Program (R25 Clinical Trial Not Allowed) (Reissue of PAR-17-455): PAR-20-289
SOURCE: National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID)
APPLICATION DEADLINE: Letter of Intent: Nov. 6, 2020. Due Date: Dec. 7, 2020.
$ AVAILABLE: The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.
ELIGIBILITY: 
• Public/state/private controlled institutions of higher education.
• Hispanic-serving institutions.
• Historically Black Colleges and Universities (HBCUs).
• Tribally Controlled Colleges and Universities (TCCUs).
• Alaska native and native Hawaiian serving institutions.
• Asian American Native American Pacific Islander Serving Institutions (AANAPISIs).
• Nonprofits with or without 501(c)(3) IRS status (other than institutions of higher education).
• Small businesses.
• For-profit organizations (other than small businesses).
• State governments.
• County governments.
• City or township governments.
• Special district governments.
• Indian/Native American tribal governments (federally recognized and other than federally recognized).
• Eligible agencies of the federal government.
• U.S. territories or possessions.
• Independent school districts.
• Public housing authorities/Indian housing authorities.
• Native American tribal organizations (other than federally recognized tribal governments).
• Faith-based or community-based organizations.
• Regional organizations.
PURPOSE: The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The  overarching goal of this R25 program is to support educational activities that complement or enhance the training of a workforce to meet the nation’s biomedical, behavioral and clinical research needs. To accomplish the stated over-arching goal, this Funding Opportunity Announcement (FOA) will support creative educational activities related to NIAID's mission areas with a primary focus on courses for skills development, research experiences and mentoring activities.
CFDA: 93.855
CONTACT: Application Submission Contacts: 
• eRA Service Desk (Questions regarding ASSIST, eRA Commons, application errors and warnings, documenting system problems that threaten submission by the due date and post-submission issues).
Finding Help Online: grants.nih.gov/support/ (preferred method of contact). Phone: 301-402-7469 or 866-504-9552 (Toll Free).
• General Grants Information (Questions regarding application instructions, application processes and NIH grant resources): Email: GrantsInfo@nih.gov (preferred method of contact). Phone: 301-945-7573.
• Grants.gov Customer Support (Questions regarding Grants.gov registration and Workspace): Contact Center Phone: 800-518-4726. Email: support@grants.gov. For more information, go to https://grants.nih.gov/grants/guide/pa-files/PAR-20-289.html.
From Grants.gov website, accessed Oct. 14, 2020. 
Subject(s): medical research, infectious diseases, health professions training.

Provocative Questions (PQs) in Multiple Myeloma Disparities Research (R01 Clinical Trial Optional): PAR-19-279
SOURCE: National Institutes of Health (NIH), National Cancer Institute (NCI)
APPLICATION DEADLINE: Due Date: Nov. 15, 2020 by 5 p.m. local time of applicant organization.
$ AVAILABLE: The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.
ELIGIBILITY: 
• Public/state/private controlled institutions of higher education.
• Hispanic-serving institutions.
• Historically Black Colleges and Universities (HBCUs).
• Tribally Controlled Colleges and Universities (TCCUs).
• Alaska native and native Hawaiian serving institutions.
• Asian American Native American Pacific Islander Serving Institutions (AANAPISIs).
• Nonprofits with or without 501(c)(3) IRS status (other than institutions of higher education).
• Small businesses.
• For-profit organizations (other than small businesses).
• State governments.
• County governments.
• City or township governments.
• Special district governments.
• Indian/Native American tribal governments (federally recognized and other than federally recognized).
• Eligible agencies of the federal government.
• U.S. territories or possessions.
• Independent school districts.
• Public housing authorities/Indian housing authorities.
• Native American tribal organizations (other than federally recognized tribal governments).
• Faith-based or community-based organizations.
• Regional organizations.
• Non-domestic (non-U.S.) entities (foreign institutions).
PURPOSE: Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) invites R01 applications for research projects designed to solve specific problems and paradoxes in multiple myeloma (MM) and disparities research identified as the NCI Multiple Myeloma Disparities Provocative Questions (MMD PQs). These problems and paradoxes phrased as questions are not intended to represent the full range of NCI's priorities in multiple myeloma research. Rather, they are meant to challenge cancer researchers to think about and elucidate specific problems in key areas of multiple myeloma and disparities research that are deemed important but have not received sufficient attention.
CFDA: 93.393, 93.394, 93.395, 93.396, 93.399
CONTACT: Application Submission Contacts: 
• eRA Service Desk (Questions regarding ASSIST, eRA Commons, application errors and warnings, documenting system problems that threaten submission by the due date and post-submission issues).
Finding Help Online: grants.nih.gov/support/ (preferred method of contact). Phone: 301-402-7469 or 866-504-9552 (Toll Free).
• General Grants Information (Questions regarding application instructions, application processes and NIH grant resources): Email: GrantsInfo@nih.gov (preferred method of contact). Phone: 301-945-7573.
• Grants.gov Customer Support (Questions regarding Grants.gov registration and Workspace): Contact Center Phone: 800-518-4726. Email: support@grants.gov. For more information, go to https://grants.nih.gov/grants/guide/pa-files/PAR-19-279.html.
From Grants.gov website, accessed Oct. 14, 2020. 
Subject(s): cancer research, health disparities.

Role of Myeloid Cells in Persistence and Eradication of HIV-1 Reservoirs from the Brain (R21 Clinical Trial Not Allowed): RFA-MH-20-702
SOURCE: National Institutes of Health (NIH), National Institute of Mental Health (NIMH), National Institute on Drug Abuse (NIDA), National Institute of Neurological Disorders and Stroke (NINDS)
APPLICATION DEADLINE: Letter of Intent: Dec. 9, 2020. Due Date: Jan. 8, 2021.
$ AVAILABLE: The following NIH components intend to commit the following amounts in Fiscal Year (FY) 2021: NIMH intends to commit an estimate of $2 million (total costs) in Fiscal Year 2021 to fund three to five awards in response to this Funding Opportunity Announcement (FOA) and the companion FOA. NIDA intends to commit approximately $1.5 million (total costs) in Fiscal Year 2021 to fund two to three awards in response to this FOA. NINDS intends to commit approximately $1.5 million (total costs) in Fiscal Year 2021 to fund two to three awards in response to this FOA.
ELIGIBILITY: 
• Public/state/private controlled institutions of higher education.
• Hispanic-serving institutions.
• Historically Black Colleges and Universities (HBCUs).
• Tribally Controlled Colleges and Universities (TCCUs).
• Alaska native and native Hawaiian serving institutions.
• Asian American Native American Pacific Islander Serving Institutions (AANAPISIs).
• Nonprofits with or without 501(c)(3) IRS status (other than institutions of higher education).
• Small businesses.
• For-profit organizations (other than small businesses).
• State governments.
• County governments.
• City or township governments.
• Special district governments.
• Indian/Native American tribal governments (federally recognized and other than federally recognized).
• Eligible agencies of the federal government.
• U.S. territories or possessions.
• Independent school districts.
• Public housing authorities/Indian housing authorities.
• Native American tribal organizations (other than federally recognized tribal governments).
• Faith-based or community-based organizations.
• Regional organizations.
PURPOSE: This Funding Opportunity Announcement (FOA) invites research grant applications studying mechanisms of HIV-1 persistence in myeloid cells and strategies to target this reservoir in the central nervous system. Basic and translational research in domestic and international settings are of interest. Multidisciplinary research teams and collaborations are encouraged but not required. 
CFDA: 93.242, 93.279, 93.853
CONTACT: Application Submission Contacts: 
• eRA Service Desk (Questions regarding ASSIST, eRA Commons, application errors and warnings, documenting system problems that threaten submission by the due date and post-submission issues).
Finding Help Online: grants.nih.gov/support/ (preferred method of contact). Phone: 301-402-7469 or 866-504-9552 (Toll Free).
• General Grants Information (Questions regarding application instructions, application processes and NIH grant resources): Email: GrantsInfo@nih.gov (preferred method of contact). Phone: 301-945-7573.
• Grants.gov Customer Support (Questions regarding Grants.gov registration and Workspace): Contact Center Phone: 800-518-4726. Email: support@grants.gov. For more information, go to https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-20-702.html
From CDC National Prevention Information Network's (NPIN) HIV/Hepatitis/STD/TB Funding Information email, Oct. 1, 2020. 
Subject(s): HIV/AIDS research, brain and nervous system disorders.

Private Funding Opportunities

America Walks: Community Change Grants
SOURCE: America Walks
APPLICATION DEADLINE: Nov. 9, 2020 by 4 p.m. CST.
$ AVAILABLE: Microgrants of up to $1,500.
ELIGIBILITY: The following are eligible to apply:
• Nonprofit with 501c3 status (must be able to provide proof of status).
• School or other education facility.
• Public office or institution.
• Organization working with a nonprofit organization.
PURPOSE: The goal for this year’s grant awards is to knit together seemingly disparate threads too often considered in isolation, including, but not limited to; racism and the public sphere; climate and environmental justice; access and inclusion; walking and moving as a mechanism for bringing about political change; and how COVID-19, the need for economic recovery and a growing awakening around racial injustice might alter the landscape of our work. Our desire is for proposed projects to have a focus on engaging in key issues of the day with new perspectives and diverse partners or audiences while highlighting the vital role that walking and transportation patterns can play in a new era. Funded projects must demonstrate that they will show increased physical activity and active transportation in a specific community, work to engage people and organizations new to the efforts of walking and walkability and demonstrate a culture of inclusive health and design. Projects will create healthy, active and engaged communities that support walking as transportation, health and recreation. Projects must show a strong and intentional foundation of equity and authentic engagement of the whole community.
CONTACT: Nicole Smith. Email: nsmith@americawalks.org. To apply, go to https://docs.google.com/forms/d/e/1FAIpQLScLDJauCLctJXaWEQox8qoAlhQWUi9MKJ02W_DEz6ji-oa6wg/viewform. For more information, go to https://americawalks.org/community-change-grants/.
From CDC Division of Nutrition, Physical Activity and Obesity Weekly Digest email, Oct. 9, 2020.
Subject(s): health promotion/wellness. 
 
American Otological Society: Clinical Investigations Grant
SOURCE: American Otological Society (AOS) Research Foundation
APPLICATION DEADLINE: Letter of Intent: Nov. 1, 2020. Due Date: Select applicants will be invited to submit a full application by Jan. 31, 2021.
$ AVAILABLE: $66,000 for one year.
ELIGIBILITY: Anybody can apply. A research proposal will qualify for review when it involves studies that pertain to the function or dysfunction of the ear, specifically the auditory or vestibular system. 
PURPOSE: The goal of this grant is to accrue preliminary data to support an National Institute on Deafness and Other Communication Disorders (NIDCD) R21 or R01 clinical trial grant application. The purpose of the American Otological Society Research Fund is to encourage and support academic research in sciences related to the ear. All the AOS grant awards may involve research on any topic related to ear disorders. The research need not be directly on an otological disease but may explore normal functions of the cochlea, labyrinth, or central auditory or vestibular systems. However, the applicant must describe how the proposed research will benefit our understanding, diagnosis or treatment of otological disorders. 
CONTACT: John S. Oghalai, M.D., Executive Secretary, Research Fund of the American Otological Society. Email: john.oghalai@med.usc.edu. Kristen Bordignon, Assistant to Dr. Oghalai. Email: administrator@americanotologicalsociety.org. For more information, go to https://www.americanotologicalsociety.org/aos-grant-submission-instructions.
From American Otological Society website, accessed Oct. 12, 2020.
Subject(s): hearing/deafness.

American Otological Society: Fellowship Grant
SOURCE: American Otological Society (AOS) Research Foundation
APPLICATION DEADLINE: Letter of Intent: Nov. 1, 2020. Due Date: Select applicants will be invited to submit a full application by Jan. 31, 2021.
$ AVAILABLE: $44,000 for one year.
ELIGIBILITY: Clinical fellows, residents, medical students, post-doctoral fellows (both M.D. and Ph.D.) and graduate students.
PURPOSE: The purpose of the American Otological Society (AOS) Research Fund is to encourage and support academic research in sciences related to the ear. All the AOS grant awards may involve research on any topic related to ear disorders. The research need not be directly on an otological disease but may explore normal functions of the cochlea, labyrinth, or central auditory or vestibular systems. However, the applicant must describe how the proposed research will benefit our understanding, diagnosis or treatment of otological disorders. 
CONTACT: John S. Oghalai, M.D., Executive Secretary, Research Fund of the American Otological Society. Email: john.oghalai@med.usc.edu. Kristen Bordignon, Assistant to Dr. Oghalai. Email: administrator@americanotologicalsociety.org. For more information, go to https://www.americanotologicalsociety.org/aos-grant-submission-instructions.
From American Otological Society website, accessed Oct. 12, 2020.
Subject(s): hearing/deafness.

ASAP Collaborative Research Network: Circuitry and Brain-Body Interactions
SOURCE: Michael J. Fox Foundation
APPLICATION DEADLINE: Due: Pre-Proposals Due: December 11, 2020 by 4 p.m. CST. Select applicants will be invited to submit a full proposal by April 13, 2021 by 4 p.m. CST.
$ AVAILABLE: Up to $9 million.
ELIGIBILITY: This Request for Applications (RFA) is open to international organizations including public and private nonprofit groups, agencies of the U.S. federal government and for-profit entities. Applications must be submitted by multidisciplinary, multi-institutional research teams consisting of three to five investigators.
PURPOSE: The ASAP Collaborative Research Network, a program of the Aligning Science Across Parkinson’s (ASAP) initiative being implemented through the Michael J. Fox Foundation, seeks to support multidisciplinary, multi-institutional research teams to address key knowledge gaps in the basic mechanisms that contribute to Parkinson’s development and progression. Applications that focus primarily on circuitry and brain-body interactions, inclusive of genetic and neuro-immune contributors to disease, will be considered.
CONTACT: Email: grants@parkinsonsroadmap.org. For more information, go to https://www.michaeljfox.org/grant/asap-collaborative-research-network-circuitry-and-brain-body-interactions.
From Michael J. Fox Foundation website, accessed Oct. 14, 2020.
Subject(s): medical research, brain and nervous system disorders.

Pancreatic Cancer Action Network: Career Development Award
SOURCE: Pancreatic Cancer Action Network (PanCAN)
APPLICATION DEADLINE: Due: Nov. 20, 2020.
$ AVAILABLE: $200,000 for two years. It is anticipated that three grants will be funded.
ELIGIBILITY: Applicants must have a doctoral degree (including Ph.D., M.D., D.O., D.C., N.D., D.D.S., D.V.M., Sc.D., D.N.S., Pharm.D. or equivalent) in the biomedical sciences or in a field applicable to health science research and may not currently be a candidate for a further doctoral degree. Employees or subcontractors of a U.S. government entity or for-profit private industry are not eligible. At the start of the grant term on July 1, 2021, applicants must meet the requirements listed below. Please refer to the full announcement for more details.
• Applicants must hold a faculty position with the title of assistant professor, instructor, research assistant professor or the equivalent.
• Applicants that have progressed to associate professor appointments are not eligible.
• If eligibility is based on a future position, the position must be confirmed at the time of application and cannot be contingent upon receiving this grant.
• If the future position is at a different institution than the applicant’s current institution, the applicant must contact PanCAN’s Research and Grants Manager at the email listed below before applying for information on additional verification materials/signatures that may be required. 
• Applicants must have completed their most recent doctoral degree within the past 11 years.
• Applicants with a medical degree must have completed their most recent doctoral degree or medical residency, whichever date is later, within the past 11 years.
• An exception to the 11-year window may be granted for parental leave or other well justified leave from research for pressing personal or family situations of generally less than 12 months duration. Applicants whose experience exceeds the maximum of 11 years but who believe they are eligible must contact PanCAN’s Research and Grants Manager at the email listed below before submitting their application to verify their eligibility.
• Have independent laboratory space as confirmed by the applicant’s institution in the Letter of Institutional Support.
• Work at an academic, medical or research institution within the United States; there are no citizenship requirements. However, by submitting an application, applicants who are not U.S. citizens or permanent residents assure that their visa status will provide sufficient time to complete the project and grant term within the United States.
• Not have currently or previously served as a principal investigator on major research awards or grants. 
PURPOSE: The Pancreatic Cancer Action Network Career Development Award represents an effort to encourage and support junior faculty to conduct pancreatic cancer research and establish successful career paths in this field. The grants provide $200,000 over two years for junior investigators that have yet to secure their first major research funding. The research proposed for funding may be basic, translational, clinical or epidemiological in nature and must have direct applicability and relevance to pancreatic cancer. Special consideration will be given to understudied areas in pancreatic cancer research. 
CONTACT: For questions about guidelines and application materials: Valerie Holzherr, Manager, Research and Grants. Email: grants@pancan.org. For technical issues regarding proposal and the online application process: Phone: 703-964-5840 or 800-875-2562. Email: pcsupport@altum.com. For program guidelines and application instructions, go to http://media.pancan.org/rsa/2021/2021-CDA-FAQ.pdf. For more information, go to https://www.pancan.org/research/grants-program/apply-for-a-pancreatic-cancer-research-grant/.
From Pancreatic Cancer Action Network website, accessed Oct. 14, 2020.
Subject(s): cancer research.

Suicide Prevention Innovation Grant: Distinguished Investigator Innovation Grants
SOURCE: American Foundation for Suicide Prevention (AFSP)
APPLICATION DEADLINE: Nov. 15, 2020.
$ AVAILABLE: Up to $125,000 over two years.
ELIGIBILITY: AFSP research grants and fellowships are awarded to individuals affiliated with not-for-profit institutions or organizations in the U.S. and abroad. Grant applications are not accepted from for-profit organizations or from federal or state government agencies. Applications from the Veterans Administration are eligible. Applications  from both private and public colleges and universities are eligible, so long as the institution is not-for-profit.  
PURPOSE: All AFSP research grants are designed to support research on suicide from a variety of disciplines, including psychiatry, medicine, psychology, genetics, epidemiology, neurobiology, sociology, nursing, social work, health services administration and many others. Grants are not intended to support the development or implementation of prevention programs, educational programs, treatments or other interventions that do not have a significant research component. Grants are awarded to investigators at the level of associate professor or higher with an established record of research and publication on suicide.
CONTACT: Email: grantsmanager@afsp.org. For more information, go to https://afsp.org/research-grant-information#grant-cycle-2020---2021.
From American Foundation for Suicide Prevention website accessed Oct. 12, 2020.
Subject(s): mental health.

Terri Brodeur Breast Cancer Foundation: Fellowship Grant
SOURCE: Terri Brodeur Breast Cancer Foundation
APPLICATION DEADLINE: Nov. 20, 2020.
$ AVAILABLE: The award period is two years with a one-year interim renewal to occur upon successful completion of the year one research goals. Stipends are $50,000 per year, with the intention that all funds are strictly used for direct support of the grantee or their research program.
ELIGIBILITY: This award is intended to support Ph.D., M.D./Ph.D. and M.D. physician scientists at earlier stages of their careers to enable them to develop independent programs and compelling careers in breast cancer research. 
PURPOSE: The Terri Brodeur Breast Cancer Foundation is a nonprofit organization dedicated to providing critical funding to researchers investigating breast cancer cures and patient treatment options. The Foundation’s grant program seeks to fund clinical and pre-clinical fellowships in high impact, breast cancer therapeutic research areas.
CONTACT: Dr. Nicholas A. Saccomano, Ph.D., Scientific Advisory Board (SAB) Terri Brodeur Breast Cancer Foundation. Email: Nick.Saccomano@Pfizer.com. For more information, go to https://www.tbbcf.org/tbbcf-research-grants/granting-process/.
From Terri Brodeur Breast Cancer Foundation website, accessed Oct. 12, 2020.
Subject(s): cancer research.

Tourette Association of America: Annual Young Investigator Award
SOURCE: Tourette Association of America (TAA)
APPLICATION DEADLINE: Pre-Proposal Due: Dec. 4, 2020. Select applicants will be invited to submit a full proposal by Feb. 1, 2021.
$ AVAILABLE: The Young Investigator Award provides up to $80,000 per year for a total of two years ($160,000 total).
ELIGIBILITY: 
• Award is open to post-doctoral fellows and independent clinical/research faculty members within five years of their first independent faculty appointment at the time of pre-proposal application submission.
• Investigators are required to have an advanced degree such as a Ph.D., M.D. or equivalent.
• Investigators outside the U.S. are welcome to apply.
• Investigators cannot have received previous early career funding support from the Tourette Association.
• Applications must include a career development component as well as an independent research project.
PURPOSE: The Tourette Association of America (TAA) aims to encourage early career researchers to invest their efforts and expertise in increasing our biological understanding of Tourette Syndrome (TS), pursing clinical research aimed at improving patient care and developing and testing new therapies.
CONTACT: Phone: 718-224-2999, ext. 222. Email: leo.neuringer@tourette.org. To submit an application for a pre-proposal, go to https://tourette.org/research-medical/pre-proposal/. For more information, go to https://tourette.org/research-medical/taa-young-investigator-award/.
From Tourette Association of America website, accessed Oct. 6, 2020.
Subject(s): medical research, brain and nervous system disorders.

Events

Webinar - AFP Virtual Education Session: Going Beyond Virtual: Reimagining Your 2021 Events 
SPONSOR: Association of Fundraising Professionals (AFP), Greater Austin Chapter
WHEN: Nov. 12, Noon-1 p.m. CST.
WHERE: Webinar.
DESCRIPTION: As the world reacted to the uncertainty of the coronavirus pandemic in 2020, events of all kinds were suddenly shifted online. Looking ahead to 2021, many understand the necessary precautions for in-person experiences, but they also know many people will not be comfortable returning to public gatherings for some time. How can nonprofits use the lessons learned from 2020 to reimagine fundraising events to maximize safety while still harnessing their supporters’ love of their causes? In this session, Tanya Fitzgerald, Certified Fund Raising Executive (CFRE) and fundraising event expert, will share strategies and tips to help attendees creatively harness their supporters’ passion. Participants will hear about a variety of engagement opportunities from virtual experiences to on-the-ground activities.
COST: Non-Member: $25. AFP Member: $10. For more information and registration, go to https://www.afpaustin.org/index.php?option=com_jevents&task=icalrepeat.detail&evid=32&Itemid=115&year=2020&month=11&day=12&title=afp-virtual-education-session-november-2020&uid=69a7934c57e8ed5d3288ecd68fcf0cd1.
CONTACT: Phone: 512-457-8145. Email: info@afpaustin.org.
From AFP Greater Austin Chapter website, accessed Oct. 14, 2020.

Webinar - Finding a Needle in a Haystack: How to Successfully Research Grants
SPONSOR: Charityhowto.com
WHEN: Nov. 11, 2-3 p.m. CST.
WHERE: Webinar.
DESCRIPTION: In this live, interactive webinar the instructor will introduce the subscription databases most commonly used by U.S. based nonprofits for foundation research and explain how to integrate that research with free research tools to draft an initial grant strategy. The instructor will suggest tools and strategies that can be used to successfully compile the information and documents collected during the research process to create a prioritized proactive grant-seeking strategy.
COST: $87. For more information and registration, go to https://www.charityhowto.com/nonprofit-webinar/new-finding-a-needle-in-a-haystack-how-to-successfully-research-grants?list=Upcoming+Live+Webinars.
CONTACT: Phone: 617-439-4511. Email: support@charityhowto.com
From charityhowto.com website, accessed Oct. 14, 2020.

Return to Alert
Last updated October 19, 2020